Newtown Veterinary Clinic is very proud to have been involved in the early clinical trial work and early publications for the anti cancer drug Stelfonta.  Stelfonta is now registered for use in both Europe and the USA.  Australian registration is expected to be approved in late 2021.

For more information on Stelfonta or general enquiries, please contact Qbiotics directly.

www.qbiotics.com

One of the first published papers:

 https://www.frontiersin.org/articles/10.3389/fvets.2019.00106/full

https://vetpracticemag.com.au/new-canine-cancer-treatment-available/